A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease
Clinical trial NCT06175767 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06175767
- Sponsor
- Mthera Pharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-14
- Primary completion
- 2025-07-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.